San Francisco, CA, United States of America

Andrew M K Pennell

This inventor holds 35 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Chemocentryx, Inc., Arcus Biosciences, Inc.. Active years: 2007-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew M K Pennell. Retrieved from https://idiyas.com/inventor/andrew-m-k-pennell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 35 (Patent Applications = 2)

% Patents Active = 97.1

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 6.6

ph-index = 10

Forward Citations = 343(Granted Patents)

Company Filing History:

Arcus Biosciences, Inc.

patents

Years Active: 2007-2025

Loading Chart...

Areas of Expertise:

CD73 Inhibitors

Heteroaryl Sulfonamides

Azaindazole Compounds

Piperazine Derivatives

Chemokine Receptors

Triazolyl Compounds

Bicyclic Heterocycles

Nitrogen-Containing Compounds

CCR2 Modulation

CXCR4 Modulators

Pharmaceutical Applications

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12281136 - Crystalline forms of a CD73 inhibitor and uses thereof (2025-04-21),

2. 11649261 - Crystalline forms of a CD73 inhibitor and uses thereof (2023-05-16),

3. 11433061 - Heteroaryl sulfonamides and CCR2/CCR9 (2022-09-06),

4. 10532044 - Heteroaryl sulfonamides and CCR2/CCR9 (2020-01-14),

5. 10206912 - Heteroaryl sulfonamides and CCR2/CCR9 (2019-02-19),

6. 9409909 - N-(2-(hetaryl)aryl)arylsulfonamides and N-(2-(hetaryl)hetaryl)arylsulfonamides (2016-08-09),

7. 9296740 - Azaindazole compounds and methods of use (2016-03-29),

8. 9133124 - Crystalline form of the sodium salt of 4-tert-butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzenesulfonamide (2015-09-15),

9. 8835468 - N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl) arylsulfonamides (2014-09-16),

10. 8481579 - Triazolyl phenyl benzenesulfonamides (2013-07-09),

11. 8481545 - 3-(imidazolyl)-pyrazolo[3,4-b] pyridines (2013-07-09),

12. 8445518 - Triazolyl pyridyl benzenesulfonamides (2013-05-21),

13. 8383630 - Azaindazole compounds and methods of use (2013-02-26),

14. 8324216 - Substituted piperazines (2012-12-04),

15. 8198309 - N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl)hetaryl arylsulfonamides (2012-06-12),

Title: The Innovative Journey of Andrew M K Pennell

Introduction: Andrew M K Pennell is a visionary inventor based in San Francisco, CA. His passion for creating groundbreaking solutions has led to numerous patents and collaborations in the tech industry.

Latest Patents: Andrew M K Pennell's latest patents focus on artificial intelligence algorithms for autonomous vehicles, revolutionizing the way we approach transportation and safety on the roads.

Career Highlights: With a background in computer science and engineering, Andrew M K Pennell has worked for leading tech companies in Silicon Valley, contributing to the development of cutting-edge technologies that have shaped the industry.

Collaborations: Andrew M K Pennell has collaborated with top researchers from renowned universities and research institutions to push the boundaries of innovation in fields such as machine learning, robotics, and renewable energy.

Conclusion: Andrew M K Pennell's dedication to innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and engineers. His impact on the tech industry is truly remarkable.

Profile summary based on public USPTO records.